KS

Kumara Swamy Koutam

Active Director Director DIN 07140828
DIN 07140828 First appointment May 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2015
Shareholding value •••• Premium profile

About Kumara Swamy Koutam

Data last updated:

Kumara Swamy Koutam is a Director at Sri Laxmi Dhanwantari Hospitals & Research Private Limited (since 2015), Director at Sri Nitha Hospitals & Research Private Limited (since 2018) and Director at Vagdhana Healthcare Private Limited (since 2019). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹19.05 Cr; the largest is Sri Laxmi Dhanwantari Hospitals & Research Private Limited at ₹17.75 Cr (FY 2024). Earlier, Kumara Swamy Koutam was a Director at Starmount Health Care Private Limited (2020–2024).

DIN 07140828
Primary Designation Director
Industry Healthcare
First Appointment 08 May 2015
Oldest Company Age 11 yrs
Largest company Sri Laxmi Dhanwantari Hospitals & Research Private Limited · ₹17.75 Cr (FY 2024)
Combined revenue ₹19.05 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 May 20152015₹17.75 Cr (FY 2024)Active
Director08 Sep 20182018₹1.30 Cr (FY 2025)Active
Vagdhana Healthcare Private Limited U85100TG2019PTC136979
Director20 Nov 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20202020₹1.60 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vagdhana Healthcare Private Limited
Sri Laxmi Dhanwantari Hospitals & Research Private Limited
Sri Nitha Hospitals & Research Private Limited
Starmount Health Care Private Limited
Premium access

Shareholding and investment profile for Kumara Swamy Koutam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumara Swamy Koutam

Kumara Swamy Koutam currently holds 3 directorships: Sri Laxmi Dhanwantari Hospitals & Research Private Limited (Director, since 08 May 2015, revenue ₹17.75 Cr (FY 2024)); Sri Nitha Hospitals & Research Private Limited (Director, since 08 Sep 2018, revenue ₹1.30 Cr (FY 2025)); Vagdhana Healthcare Private Limited (Director, since 20 Nov 2019).

Kumara Swamy Koutam was first appointed on 08 May 2015 as Director at Sri Laxmi Dhanwantari Hospitals & Research Private Limited. The most recent appointment on record is 21 Jan 2020 at Starmount Health Care Private Limited.

The 2 current companies of Kumara Swamy Koutam that report revenue have a combined latest revenue of ₹19.05 Cr: Sri Laxmi Dhanwantari Hospitals & Research Private Limited ₹17.75 Cr (FY 2024); Sri Nitha Hospitals & Research Private Limited ₹1.30 Cr (FY 2025).

Kumara Swamy Koutam held 1 earlier board appointment: Starmount Health Care Private Limited (Director, 21 Jan 2020 to 31 May 2024).

The current boards of Kumara Swamy Koutam's companies include Chetan Chouhan (Sri Laxmi Dhanwantari Hospitals & Research Private Limited), Nutan Pawar (Sri Laxmi Dhanwantari Hospitals & Research Private Limited), Siripuram Srinivas (Sri Laxmi Dhanwantari Hospitals & Research Private Limited), Srinivas Gumudavelly (Sri Laxmi Dhanwantari Hospitals & Research Private Limited), Anitha Kottapally (Sri Nitha Hospitals & Research Private Limited), Srinivas Kottapalli (Sri Nitha Hospitals & Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available